-

SELECT MEDICAL STOCK ALERT: Does $16.50 Per Share Represent a Fair Shareholder Buyout Price? Kaskela Law Firm Announces Investigation into Fairness of Buyout Offer and Encourages Investors to Contact the Firm – SEM

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC is investigating the recently announced buyout of Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) shareholders to determine whether the $16.50 per share buyout offer is fair to the company’s investors or if it undervalues the company’s shares.

Kaskela Law is investigating the recently announced buyout of Select Medical Holdings Corp. (NYSE: SEM) shareholders to determine whether the $16.50 per share buyout offer is fair to the company’s investors or if it undervalues the company's shares.

Share

Click here for additional information: https://kaskelalaw.com/case/select-medical/

On March 2, 2026, Select Medical announced that it had agreed to be acquired by an investment consortium at a price of $16.50 per share in cash. Following the closing of the proposed transaction the company’s shares will no longer be publicly traded.

The investigation seeks to determine whether investors will be receiving sufficient financial consideration for their Select Medical shares, and whether the company’s representatives breached their fiduciary duties in agreeing to the $16.50 per share buyout price. Notably, at the time the proposed transaction was announced, at least one stock analyst was maintaining a price target for Select Medical’s shares of $19.00 per share.

The investigation seeks to determine whether investors will be receiving sufficient financial consideration for their Select Medical shares, and whether the company’s representatives breached their fiduciary duties in agreeing to the $16.50 per share buyout price.

Select Medical investors who would like to learn more about the investigation and their legal rights and options are encouraged to contact lead investigative attorney Adrienne Bell, Esq. at (484) 229-0750 or by email at abell@kaskelalaw.com. You can also click on the following link or paste it into your browser to learn more:

https://kaskelalaw.com/case/select-medical/

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation in contingent litigation. For additional information about Kaskela Law LLC, including the firm's recent notable recoveries for investors, please visit www.kaskelalaw.com.

This communication may constitute attorney advertising in certain jurisdictions.

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
(skaskela@kaskelalaw.com)
Adrienne Bell, Esq.
(abell@kaskelalaw.com)
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 - 0750
www.kaskelalaw.com

Kaskela Law LLC 

NYSE:SEM

Release Versions

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
(skaskela@kaskelalaw.com)
Adrienne Bell, Esq.
(abell@kaskelalaw.com)
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 - 0750
www.kaskelalaw.com

More News From Kaskela Law LLC 

SHAREHOLDER BUYOUT ALERT: Kaskela Law LLC Announces Investigation Into Proposed Buyout of The Baldwin Insurance Group, Inc. (BWIN) Shareholders at $32.50 Per Share – Fair Price or Insufficiently Low?

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law announces that it has launched an investigation into the fairness of the recently announced proposed buyout of The Baldwin Insurance Group, Inc. (NASDAQ: BWIN) (“Baldwin”) shareholders to determine whether the proposed buyout price undervalues the company’s shares. Click here for additional information: https://kaskelalaw.com/case/baldwin-group-buyout/ On September 14, 2026, Baldwin announced that it would be acquired by Sequence Holdings and DFO Manag...

SHAREHOLDER BUYOUT ALERT: Kaskela Law LLC Announces Investigation into Proposed Buyout of Surgery Partners, Inc. (SGRY) Shareholders at $23.50 Per Share – Fair Price or Insufficiently Low?

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law announces that it has launched an investigation into the fairness of the proposed buyout of Surgery Partners, Inc. (NASDAQ: SGRY) shareholders to determine whether the proposed buyout price undervalues the company’s shares.Click here for additional information: https://kaskelalaw.com/case/surgery-partners/On October 26, 2026, Surgery Partners announced that it had agreed to be acquired by HealthSpan Partners at a price of $23.50 per share in cash. Follo...

SHAREHOLDER BUYOUT ALERT: Kaskela Law LLC Announces Investigation into Proposed Buyout of CCC Intelligent Solutions Holdings (CCC) Shareholders at $7.75 Per Share – Fair Price or Insufficiently Low?

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law announces that it has launched an investigation into the fairness of the recently announced proposed buyout of CCC Intelligent Solutions Holdings Inc. (NASDAQ: CCC) (“CCC”) shareholders to determine whether the proposed buyout price undervalues the company’s shares.Click here for additional information: https://kaskelalaw.com/case/ccc-intelligent-solutions-holdings/On October 15, 2026, CCC announced that it had agreed to be acquired by a consortium of p...
Back to Newsroom